Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
Bonn et al sustain that the COVID-19 pandemic should be considered an opportunity to begin addressing the harms caused by the criminalization of drug use by decriminalizing personal drug use and providing a sustainable safe supply of drugs.
In this webinar, Transform Drug Policy Foundation introduces their proposals for the regulation of stimulants. In doing so, they will lay out a realistic alternative to the prohibition of stimulant drugs.